Skip to main content

Want a detailed portfolio tracker?

Fortress Biotech (FBIO) P/E (2011 - 2026)

Fortress Biotech (FBIO) P/E from Nov 17, 2011 to Jun 2, 2026. The TTM Fortress Biotech (FBIO) P/E is 0.68. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Fortress Biotech (FBIO)

YearP/EChange
20260.68-95.82%
202516.22-1693.11%
2024-1.02+221.89%
2023-0.32-58.23%
2022-0.76-80.37%
2021-3.86-35.11%
2020-5.94+37.56%
2019-4.32+666.05%
2018-0.56-79.17%
2017-2.71+3.12%
2016-2.63-3.12%
2015-2.71-49.35%
2014-5.35+137.57%
2013-2.25-33.44%
2012-3.38+210.21%
2011-1.09N/A

Comparison Fortress Biotech (FBIO) P/E with competitors

Fortress Biotech (FBIO) P/E is 0.68.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.75%
NBYStablecoin Development Corp0.10-84.92%
ENLVEnlivex Therapeutics Ltd0.15-77.84%
FGENFibroGen Inc0.24-64.59%
TRAWTraws Pharma Inc0.47-30.25%
CHRSCoherus Biosciences Inc0.98+44.29%
ORMPOramed Pharmaceuticals Inc1.47+117.36%
AGENAgenus Inc2.05+202.19%
VIVSVivoSim Labs Inc2.54+274.08%
INVAInnoviva Inc3.19+370.37%
CRMDCorMedix Inc3.65+437.82%
ABEOAbeona Therapeutics Inc4.20+520.33%
VXRTVaxart Inc4.26+528.68%
CVACCureVac N.V.4.45+555.82%
SRPTSarepta Therapeutics Inc4.62+582.17%
GLPGGalapagos NV4.86+616.78%
RIGLRigel Pharmaceuticals4.92+625.73%
ZVRAZevra Therapeutics Inc4.97+633.77%
ABUSArbutus Biopharma Corp5.69+739.95%
CGENCompugen Ltd7.38+989.30%
AUPHAurinia Pharmaceuticals Inc9.25+1264.80%
ACADAcadia Pharmaceuticals Inc9.59+1314.46%
OMEROmeros Corporation9.88+1358.03%
PLXProtalix BioTherapeutics Inc9.91+1361.83%
SPROSpero Therapeutics Inc10.73+1483.62%
ADMAAdma Biologics Inc11.33+1571.53%
SVASinovac Biotech Ltd11.44+1587.08%
TBPHTheravance Biopharma Inc11.78+1637.33%
HRMYHarmony Biosciences Holdings Inc12.18+1696.90%
TGTXTG Therapeutics Inc13.18+1844.28%
INCYIncyte Corp13.38+1874.17%
SABSSAB Biotherapeutics Inc14.06+1973.85%
XOMAXOMA Corp14.95+2104.78%
REGNRegeneron Pharmaceuticals Inc14.98+2109.94%
PBYIPuma Biotechnology Inc15.05+2120.30%
EXELExelixis Inc15.79+2230.11%
NAGENiagen Bioscience Inc16.35+2312.74%
CPRXCatalyst Pharmaceuticals Inc17.34+2458.76%
MDXGMimedx Group Inc17.38+2463.28%
ARGXArgen X SE23.07+3303.61%
HALOHalozyme Therapeutics Inc23.20+3322.64%
XOMAOXOMA Corp25.34+3638.96%
VRTXVertex Pharmaceuticals Inc25.66+3684.84%
XOMAPXOMA Corp25.67+3686.95%
CTMXCytomX Therapeutics Inc25.70+3691.05%
ASNDAscendis Pharma A/S26.35+3787.86%
RPRXRoyalty Pharma plc - Class A27.50+3956.23%
SLNOSoleno Therapeutics Inc29.02+4180.45%
LGNDLigand Pharmaceuticals Inc - Class B30.19+4353.23%
BMRNBiomarin Pharmaceutical Inc37.51+5433.22%
APLSApellis Pharmaceuticals Inc39.02+5656.56%
KRYSKrystal Biotech Inc39.70+5756.34%
GMABGenmab40.20+5830.99%
ONCBeiGene Ltd67.03+9788.09%
TECHBio-Techne Corp68.59+10019.42%
VCELVericel Corp80.63+11794.75%
PHARPharming Group N.V.87.74+12843.79%
ALNYAlnylam Pharmaceuticals Inc124.93+18330.73%
TLXTelix Pharmaceuticals Ltd139.89+20537.25%
CORTCorcept Therapeutics Inc158.39+23266.24%